Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    B1971015
Show Display Options
Rank Status Study
1 Completed A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Conditions: Vaccines;   Meningococcal Vaccines
Interventions: Biological: rLP2086 + MCV4 + Tdap;   Biological: MCV4 + Tdap + saline;   Biological: rLP2086 + saline

Indicates status has not been verified in more than two years